Black Diamond Therapeutics, Inc. (BDTX)
Largest Insider Buys in Sector
BDTX Stock Price History Chart
BDTX Stock Performance
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Black Diamond Therapeutics, Inc.
Over the last 12 months, insiders at Black Diamond Therapeutics, Inc. have bought $25.17M and sold $167,500 worth of Black Diamond Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Black Diamond Therapeutics, Inc. have bought $36M and sold $19.78M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. (director) — $116.98M. Behbahani Ali (director) — $40M. BIOTECH GROWTH N V (10 percent owner) — $30.98M.
The last purchase of 400,000 shares for transaction amount of $934,080 was made by BIOTECH GROWTH N V (10 percent owner) on 2023‑10‑17.
List of Insider Buy and Sell Transactions, Black Diamond Therapeutics, Inc.
| 2023-10-17 | BIOTECH GROWTH N V | 10 percent owner | 400,000 0.7707% | $2.34 | $934,080 | +88.46% | ||
| 2023-07-05 | Behbahani Ali | director | 1M 2.8199% | $5.00 | $5M | -26.54% | ||
| 2023-07-05 | RA CAPITAL MANAGEMENT, L.P. | director | 935,850 2.639% | $5.00 | $4.68M | -26.54% | ||
| 2023-06-30 | BIOTECH GROWTH N V | 10 percent owner | 1M 2.7138% | $5.00 | $5M | -28.91% | ||
| 2023-06-27 | Sale | Epstein David M. | SEE REMARKS | 25,000 0.0743% | $6.70 | $167,500 | -41.75% | |
| 2023-06-27 | BIOTECH GROWTH N V | 10 percent owner | 1.74M 4.2378% | $5.49 | $9.56M | -41.75% | ||
| 2022-12-22 | Ni Fang | SEE REMARKS | 36,363 0.0972% | $1.28 | $46,596 | +73.11% | ||
| 2022-12-21 | Ni Fang | SEE REMARKS | 20,000 0.0546% | $1.29 | $25,770 | +74.62% | ||
| 2022-10-31 | BIOTECH GROWTH N V | director | 99,801 0.268% | $2.25 | $224,912 | -6.28% | ||
| 2022-10-28 | BIOTECH GROWTH N V | director | 172,974 0.4696% | $2.18 | $376,962 | -1.81% | ||
| 2022-10-27 | BIOTECH GROWTH N V | director | 191,678 0.5124% | $1.87 | $359,224 | +12.69% | ||
| 2022-10-21 | BIOTECH GROWTH N V | director | 87,850 0.2313% | $1.51 | $132,750 | +37.97% | ||
| 2022-10-20 | BIOTECH GROWTH N V | director | 53,734 0.144% | $1.42 | $76,345 | +48.97% | ||
| 2022-10-19 | BIOTECH GROWTH N V | director | 77,689 0.2096% | $1.32 | $102,775 | +61.48% | ||
| 2022-06-29 | Ni Fang | SEE REMARKS | 25,000 0.0681% | $2.44 | $61,018 | -16.60% | ||
| 2022-04-27 | BB BIOTECH AG | 150,000 0.4047% | $2.66 | $399,480 | -22.79% | |||
| 2022-04-18 | BB BIOTECH AG | 150,000 0.4099% | $3.29 | $493,935 | -35.24% | |||
| 2022-04-12 | BB BIOTECH AG | 150,000 0.4078% | $3.42 | $513,600 | -37.46% | |||
| 2021-05-12 | Sale | Hatzis-Schoch Brent | See Remarks | 4,078 0.0111% | $27.42 | $111,805 | -72.50% | |
| 2021-05-03 | Sale | Roberts Christopher D. | Chief Scientific Officer | 2,500 0.007% | $26.64 | $66,602 | -70.20% |
Insider Historical Profitability
| BIOTECH GROWTH N V | 10 percent owner | 8517839 16.4962% | $4.69 | 9 | 0 | +25.51% |
| Behbahani Ali | director | 4448757 8.6157% | $4.69 | 2 | 0 | <0.0001% |
| RA CAPITAL MANAGEMENT, L.P. | director | 3213828 6.2241% | $4.69 | 1 | 0 | |
| Epstein David M. | SEE REMARKS | 671423 1.3003% | $4.69 | 0 | 5 | |
| BB BIOTECH AG | 4438402 8.5957% | $4.69 | 3 | 0 | <0.0001% | |
| Shah Rajeev M. | director | 1924164 3.7265% | $4.69 | 1 | 0 | <0.0001% |
| Bolzon Bradley J PhD | 874099 1.6928% | $4.69 | 1 | 27 | <0.0001% | |
| Versant Venture Capital VI, L.P. | 10 percent owner | 874099 1.6928% | $4.69 | 1 | 27 | <0.0001% |
| Flynn James E | 10 percent owner | 778790 1.5083% | $4.69 | 1 | 0 | <0.0001% |
| Ni Fang | SEE REMARKS | 125389 0.2428% | $4.69 | 3 | 0 | +43.71% |
| Hatzis-Schoch Brent | See Remarks | 8400 0.0163% | $4.69 | 1 | 9 | <0.0001% |
| INGRAM ROBERT ALEXANDER | director | 5000 0.0097% | $4.69 | 1 | 0 | <0.0001% |
| Roberts Christopher D. | Chief Scientific Officer | 3200 0.0062% | $4.69 | 0 | 10 | |
| Leggett Thomas | Chief Financial Officer | 0 0% | $4.69 | 0 | 5 |
Institutional Investor Ownership
| Bellevue Group | $43.19M | 15.14 | 8.52M | -0.21% | -$91,260.00 | 0.66 | |
| T Rowe Price Investment Management Inc | $34.1M | 11.96 | 6.73M | +71.22% | +$14.18M | 0.02 | |
| Nea Management Company Llc | $22.56M | 7.91 | 4.45M | 0% | +$0 | 0.26 | |
| RA Capital Management, L.P. | $17.88M | 6.27 | 3.53M | 0% | +$0 | 0.02 | |
| The Vanguard Group | $9.66M | 3.39 | 1.91M | -2.15% | -$211,890.51 | <0.0001 | |
| Tang Capital Management, LLC | $8.13M | 2.85 | 1.6M | -11.09% | -$1.01M | 0.03 | |
| BlackRock | $7M | 2.45 | 1.38M | +2.26% | +$154,508.24 | <0.0001 | |
| Artal Group S A | $5.31M | 1.86 | 1.05M | -48.86% | -$5.07M | 0.03 | |
| Laurion Capital Management LP | $4.45M | 1.56 | 878,286 | New | +$4.45M | 0.12 | |
| Kennedy Capital Management Inc | $3.64M | 1.28 | 717,183 | -3.2% | -$120,250.27 | 0.08 | |
| Blue Owl Capital Holdings Lp | $3.52M | 1.24 | 695,000 | 0% | +$0 | 0.66 | |
| Driehaus Capital Management LLC | $3.07M | 1.08 | 605,901 | -13.07% | -$461,714.75 | 0.03 | |
| Millennium Management LLC | $2.77M | 0.97 | 546,237 | +348.44% | +$2.15M | <0.01 | |
| Boxer Capital, LLC | $2.57M | 0.9 | 506,000 | 0% | +$0 | 0.13 | |
| Susquehanna International Group | $2.15M | 0.75 | 423,923 | +92.42% | +$1.03M | <0.01 | |
| Geode Capital Management | $1.94M | 0.68 | 382,613 | +9.18% | +$163,125.79 | <0.0001 | |
| Two Sigma | $1.82M | 0.64 | 358,064 | -2.51% | -$46,791.02 | <0.01 | |
| Goldman Sachs | $1.69M | 0.59 | 333,248 | +624.69% | +$1.46M | <0.0001 | |
| Verition Fund Management Llc | $1.67M | 0.59 | 328,906 | -78.84% | -$6.21M | 0.02 | |
| Connor Clark & Lunn Investment Management Ltd | $1.59M | 0.56 | 314,502 | New | +$1.59M | <0.01 | |
| Ubs Oconnor Llc | $1.3M | 0.46 | 257,000 | New | +$1.3M | 0.11 | |
| Jane Street Capital | $1.27M | 0.45 | 250,555 | +353.33% | +$990,095.07 | <0.01 | |
| Renaissance Technologies | $1.08M | 0.38 | 212,600 | -52.8% | -$1.21M | <0.01 | |
| Bridgeway Capital Management | $877,110.00 | 0.31 | 173,000 | -9.9% | -$96,330.00 | 0.02 | |
| Qube Research & Technologies | $875,229.00 | 0.31 | 172,629 | +269.58% | +$638,409.31 | <0.01 | |
| Squarepoint Ops LLC | $868,876.00 | 0.31 | 171,376 | +18.31% | +$134,476.63 | <0.01 | |
| Acadian Asset Management | $864,000.00 | 0.3 | 170,510 | +13.75% | +$104,464.40 | <0.01 | |
| Barclays | $848,000.00 | 0.3 | 167,246 | 0% | +$0 | <0.0001 | |
| Wellington Management Company | $840,028.00 | 0.3 | 165,686 | New | +$840,028.00 | <0.0001 | |
| Stifel | $751,881.00 | 0.26 | 148,300 | +32.77% | +$185,562.00 | <0.01 | |
| Newtyn Management | $633,750.00 | 0.22 | 125,000 | -55.36% | -$785,850.00 | 0.14 | |
| Hrt Financial Llc | $634,000.00 | 0.22 | 125,094 | New | +$634,000.00 | <0.01 | |
| Man Group Plc | $605,662.00 | 0.21 | 119,460 | New | +$605,662.00 | <0.01 | |
| State Street | $593,616.00 | 0.21 | 117,084 | +1.12% | +$6,591.00 | <0.0001 | |
| ExodusPoint Capital Management, LP | $586,000.00 | 0.21 | 115,576 | +295.32% | +$437,765.97 | 0.01 | |
| Citigroup | $570,127.00 | 0.2 | 112,451 | +107.77% | +$295,718.11 | <0.0001 | |
| Dimensional Fund Advisors | $566,147.00 | 0.2 | 111,666 | +0.95% | +$5,343.78 | <0.0001 | |
| Northern Trust | $527,442.00 | 0.19 | 104,032 | -5.16% | -$28,680.98 | <0.0001 | |
| Foundations Investment Advisors | $489,255.00 | 0.17 | 96,500 | New | +$489,255.00 | 0.02 | |
| Two Sigma Advisers LP | $488,241.00 | 0.17 | 96,300 | -6.41% | -$33,462.00 | <0.01 | |
| Marathon Trading Investment Management Llc | $478,608.00 | 0.17 | 94,400 | New | +$478,608.00 | 0.19 | |
| Td Asset Management Inc | $359,199.00 | 0.13 | 70,848 | New | +$359,199.00 | <0.0001 | |
| Castleview Partners LLC | $323,800.00 | 0.11 | 63,866 | New | +$323,800.00 | 0.22 | |
| Morgan Stanley | $298,613.00 | 0.11 | 58,898 | +397.83% | +$238,629.80 | <0.0001 | |
| Cornercap Investment Counsel Inc | $246,549.00 | 0.09 | 48,629 | -41.26% | -$173,165.83 | 0.04 | |
| Cubist Systematic Strategies | $221,554.00 | 0.08 | 43,699 | +192.93% | +$145,919.72 | <0.01 | |
| Jump Financial Llc | $195,033.00 | 0.07 | 38,468 | -1.08% | -$2,129.40 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $188,325.00 | 0.07 | 37,145 | New | +$188,325.00 | 0.02 | |
| Balyasny Asset Management Llc | $177,049.00 | 0.06 | 34,921 | New | +$177,049.00 | <0.0001 | |
| Pale Fire Capital Se | $170,844.00 | 0.06 | 33,697 | -34.06% | -$88,233.32 | <0.01 |